论文部分内容阅读
我们采用美国赛生公司生产的胸腺肽α1 ,即Ｔα1 (商品名日达仙 )联合肝动脉化学栓塞 (ＴＡＣＥ)治疗 1 0例晚期肝癌患者 ,取得较好疗效 ,现报告如下。材料与方法一、临床资料1 0例原发性肝癌患者为 1 998年 7月至 1 999年 6月我院所收治。男性 8例、女性 2例 ,平均年龄 54岁 (
We used thymosin α1 produced by American Saisheng Co., Ltd., namely Tα1 (trade name Rixian) and hepatic arterial chemoembolization (TACE) to treat 10 patients with advanced hepatocellular carcinoma. The results are as follows: Materials and Methods 1. Clinical data A total of 10 patients with primary liver cancer were admitted to our hospital from July 998 to June 1999. 8 males and 2 females with an average age of 54 years (